Securities code: 002411 securities abbreviation: Yanan Bicon Pharmaceutical Listed Company(002411) Announcement No.: 2022-014 Yanan Bicon Pharmaceutical Listed Company(002411)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Important:
1. The shareholders' meeting did not veto or modify the proposal;
2. The shareholders' meeting did not change the resolution of the previous shareholders' meeting;
3. The general meeting of shareholders was held by combining on-site voting and online voting. For the proposals deliberated at the meeting, separate vote counting shall be implemented for small and medium-sized investors (small and medium-sized investors refer to other shareholders except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the listed company).
1、 Meetings held
1. Meeting time:
The on-site meeting will be held at 14:00 p.m. on Wednesday, February 9, 2022
Online voting time: Wednesday, February 9, 2022
Among them, the specific time of online voting through the trading system of Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange") is: 9:15 to 9:25 a.m., 9:30 to 11:30 p.m. and 13:00 to 15:00 p.m. on Wednesday, February 9, 2022; The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 a.m. to 15:00 p.m. on Wednesday, February 9, 2022.
2. Venue of the on-site meeting: conference room, 8th floor, North building, Finance Bureau, No. 18, Zhongwu South Road, Xinyi City, Jiangsu Province. 3. Convening method: the shareholders' meeting adopts the combination of on-site voting and online voting.
4. Convener: the board of directors of the company.
5. Moderator: Mr. Han Wenxiong, chairman of the company.
6. The convening, convening and voting procedures of this meeting comply with the provisions of the company law of the people's Republic of China, the rules for the general meeting of shareholders of listed companies and other laws, administrative regulations, departmental rules, normative documents and the articles of association.
2、 Attendance at the meeting
1. Overall attendance at the meeting
A total of 29 shareholders and shareholders' agents participated in the general meeting, holding 631473915 (representative) shares, accounting for 41.2113% of the total voting shares of the company.
Among them, a total of 26 small and medium-sized investors (except directors, supervisors, senior managers and other shareholders who individually or jointly hold more than 5% of the shares of the company) attended the meeting, holding 1248700 (representative) shares, accounting for 0.0815% of the total voting shares of the company.
Some directors and supervisors of the company attended the meeting, and some senior managers of the company and witness lawyers hired by the company attended the meeting as nonvoting delegates.
2. Attendance at site meetings
Six shareholders and their agents attended the on-site meeting, holding 631091415 (representative) shares, accounting for 41.1863% of the total voting shares of the company.
3. Online voting
A total of 23 shareholders voted online, holding 382500 (representative) shares, accounting for 0.0250% of the total voting shares of the company.
3、 Deliberation and voting of proposals
The general meeting of shareholders deliberated and adopted the following proposals by means of on-site open ballot and online voting:
Proposal on proposed change of accounting firm.
Voting results: 631434215 shares were approved, accounting for 99.9937% of the shares held by all shareholders attending the meeting; Against 39600 shares, accounting for 0.0063% of the shares held by all shareholders attending the meeting; Abstain 100 shares, accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Among them, the voting situation of small and medium-sized investors is: 1209000 shares are agreed, accounting for 96.8207% of the shares held by small and medium-sized shareholders attending the meeting; Against 39600 shares, accounting for 3.1713% of the shares held by minority shareholders attending the meeting; Abstained 100 shares, accounting for 0.0080% of the shares held by minority shareholders attending the meeting.
4、 Legal opinions issued by lawyers
The shareholders' meeting was witnessed by Chen Zhijun and Li Xuehong, lawyers of Shanghai Yingming law firm, and issued the legal opinion on the first extraordinary shareholders' meeting in Yanan Bicon Pharmaceutical Listed Company(002411) 2022. The concluding opinions are: the convening and convening procedures of the company's shareholders' meeting, the qualifications of the participants The qualifications of the convener and the voting procedures of the meeting comply with the provisions of the company law, the rules of the general meeting of shareholders and the articles of association. The voting results of the general meeting of shareholders are legal and valid.
5、 Documents for future reference
1. Yanan Bicon Pharmaceutical Listed Company(002411) resolution of the first extraordinary general meeting of shareholders in 2022;
2. Legal opinion of the first interim general meeting of shareholders of Shanghai Mingying {0021} issued in 2022.
It is hereby announced.
Yanan Bicon Pharmaceutical Listed Company(002411) board of directors
February 10, 2002
